id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-3971-0001,FDA,FDA-2024-N-3971,"Medical Devices; Hematology and Pathology Devices; Classification of the Heparin and Direct Oral Factor Xa
Inhibitor Drug Test System",Rule,Final Rule,2024-09-05T04:00:00Z,2024,9,2024-09-05T04:00:00Z,,2024-09-05T13:05:27Z,2024-19824,0,0,09000064866c29e1